Author:
Abbot Stewart,Agbanyo Francisca,Ahlfors Jan-Eric,Baghbaderani Behnam A.,Bartido Shirley,Bharti Kapil,Burke Carl,Carlsson Bjorn,Cavagnaro Joy,Creasey Abla,DiGiusto David,Francissen Kathy,Gaffney Andrew,Goldring Christopher,Gorba Thorsten,Griffiths Elwyn,Hanatani Tadaaki,Hayakawa Takao,Heki Tatsuo,Hoogendoorn Karin,Kawamata Shin,Kimura Hironobu,Kirkeby Agnete,Knezevic Ivana,Lebkowski Jane,Lin Stephen,Lin-Gibson Shen,Lubiniecki Anthony,O'Shea Orla,Pera Martin,Petricciani John,Pigeau Gary,Ratcliffe Anthony,Sato Yoji,Schumann Gerald G.,Shingleton William,Stacey (Chair) Glyn,Sullivan Stephen,Svendsen Clive N.,Trouvin Jean-Hugues,Vandeputte Joris,Yuan Bao-Zhu,Zoon Kathryn
Funder
CCRM
Georgia Tech – Marcus Center
IQVIA
Lonza
OIRM
Stemcell Technologies
ThermoFisher Scientific
CIRM
Subject
Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology
Reference18 articles.
1. Cellular & gene therapy guidances;U.S. Food and Drug Administration,2006
2. Multidisciplinary: cell therapy and tissue engineering;European Medicines Agency,2008
3. Regulation (EC) No 1394/2007 of the European Parliament and of the Council on advanced therapy medicinal products and amending directive 2001/83/EC and regulation (EC) No 726/2004,2007
4. Directive (EC) 2001/83 of the European Parliament and of the Council on the Community code relating to medicinal products for human use;Orkesterjournalen,2001
5. Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells;Orkesterjournalen,2004